Literature DB >> 18691550

Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis.

Toshiharu Sakurai1, Guobin He, Atsushi Matsuzawa, Guann-Yi Yu, Shin Maeda, Gary Hardiman, Michael Karin.   

Abstract

Hepatocyte I kappaB kinase beta (IKK beta) inhibits hepatocarcinogenesis by suppressing accumulation of reactive oxygen species (ROS) and liver damage, whereas JNK1 activation promotes ROS accumulation, liver damage, and carcinogenesis. We examined whether hepatocyte p38 alpha, found to inhibit liver carcinogenesis, acts similarly to IKK beta in control of ROS metabolism and cell death. Hepatocyte-specific p38 alpha ablation enhanced ROS accumulation and liver damage, which were prevented upon administration of an antioxidant. In addition to elevated ROS accumulation, hepatocyte death, augmented by loss of either IKK beta or p38 alpha, was associated with release of IL-1 alpha. Inhibition of IL-1 alpha action or ablation of its receptor inhibited carcinogen-induced compensatory proliferation and liver tumorigenesis. IL-1 alpha release by necrotic hepatocytes is therefore an important mediator of liver tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691550      PMCID: PMC2707922          DOI: 10.1016/j.ccr.2008.06.016

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  53 in total

1.  Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators.

Authors:  Jin Mo Park; Florian R Greten; Athena Wong; Randal J Westrick; J Simon C Arthur; Kinya Otsu; Alexander Hoffmann; Marc Montminy; Michael Karin
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

Review 2.  Liver regeneration.

Authors:  Nelson Fausto; Jean S Campbell; Kimberly J Riehle
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Novel aspects of oxidative stress-associated carcinogenesis.

Authors:  Shinya Toyokuni
Journal:  Antioxid Redox Signal       Date:  2006 Jul-Aug       Impact factor: 8.401

Review 4.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

5.  Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.

Authors:  Toshiharu Sakurai; Shin Maeda; Lufen Chang; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

6.  Attenuated phosphorylation of heat shock protein 27 correlates with tumor progression in patients with hepatocellular carcinoma.

Authors:  Eisuke Yasuda; Takashi Kumada; Shinji Takai; Akira Ishisaki; Takahiro Noda; Rie Matsushima-Nishiwaki; Naoki Yoshimi; Kanefusa Kato; Hidenori Toyoda; Yuji Kaneoka; Akihiro Yamaguchi; Osamu Kozawa
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

Review 7.  Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties.

Authors:  Carmen Garrido; Mathilde Brunet; Celine Didelot; Yael Zermati; Elise Schmitt; Guido Kroemer
Journal:  Cell Cycle       Date:  2006-11-15       Impact factor: 4.534

8.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.

Authors:  Tom Luedde; Naiara Beraza; Vasileios Kotsikoris; Geert van Loo; Arianna Nenci; Rita De Vos; Tania Roskams; Christian Trautwein; Manolis Pasparakis
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

9.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

10.  Progression of fibrosis in chronic hepatitis C.

Authors:  Marc G Ghany; David E Kleiner; Harvey Alter; Edward Doo; Farooq Khokar; Kittichai Promrat; David Herion; Yoon Park; T Jake Liang; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  210 in total

Review 1.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression.

Authors:  Kei Sakamoto; Yohko Hikiba; Hayato Nakagawa; Yoku Hayakawa; Ayako Yanai; Masao Akanuma; Keiji Ogura; Yoshihiro Hirata; Klaus H Kaestner; Masao Omata; Shin Maeda
Journal:  Gastroenterology       Date:  2010-03-25       Impact factor: 22.682

Review 4.  MAPK signaling in inflammation-associated cancer development.

Authors:  Pengyu Huang; Jiahuai Han; Lijian Hui
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

5.  The dual role of osteopontin in acetaminophen hepatotoxicity.

Authors:  Chun-yan He; Bei-bei Liang; Xiao-yu Fan; Lei Cao; Rui Chen; Ya-jun Guo; Jian Zhao
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

6.  Interleukin-33 in the human placenta.

Authors:  Vanessa Topping; Roberto Romero; Nandor Gabor Than; Adi L Tarca; Zhonghui Xu; Sun Young Kim; Bing Wang; Lami Yeo; Chong Jai Kim; Sonia S Hassan; Jung-Sun Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2012-11-23

7.  Targeted deletion of hepatocyte Ikkbeta confers growth advantages.

Authors:  Katherine S Koch; Shin Maeda; Guobin He; Michael Karin; Hyam L Leffert
Journal:  Biochem Biophys Res Commun       Date:  2009-01-24       Impact factor: 3.575

8.  IL-1 mediates pulmonary and systemic inflammatory responses to chorioamnionitis induced by lipopolysaccharide.

Authors:  Suhas G Kallapur; Ilias Nitsos; Timothy J M Moss; Graeme R Polglase; J Jane Pillow; Fook-Choe Cheah; Boris W Kramer; John P Newnham; Machiko Ikegami; Alan H Jobe
Journal:  Am J Respir Crit Care Med       Date:  2009-02-20       Impact factor: 21.405

9.  Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Authors:  Neveen Said; Henry F Frierson; Marta Sanchez-Carbayo; Rolf A Brekken; Dan Theodorescu
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

10.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.